Press release
Global Hypertension Drug Market Worth USD 32.5 Billion by 2025 | CAGR of 4.89%
Global Hypertension Drug Market
The Global Hypertension Drug Market was valued at USD 21.5 Billion in the year 2017 and is expected to reach USD 32.5 Billion by 2025 at an increasing CAGR of 4.89%during the forecast period.
Hypertension is also known as High blood pressure, it is a common disease in which blood flows through blood vessels or arteries at higher than normal pressures. Hypertension is a chronic disease, which can lead to stroke, heart failure, and kidney diseases. The main purpose of hypertension drugs is to reduce and control high blood pressure to protect organs like brain, heart, kidneys.
Browse details of research report developed on Global Hypertension Drug Market @ https://www.researchcosmos.com/reports/global-hypertension-drug-market-forecast-2017-2025-industry-analysis-report/8941611
Underlying Causes:
The market for Global Hypertension Drug is mainly driven due to the factors like increasing prevalence hypertension diseases across the globe, growing demand for hypertension drugs, rising number of geriatric population, increasing awareness about hypertension treatment among the people, increasing healthcare expenditure. Other factors like the advancement of technologies and introduction of new drugs and advanced treatments related to hypertension disorders and improving healthcare facilities in the developing countries are expected to propel the growth of the global hypertension drugs market. However, lack of awareness about hypertension drugs in the developing countries, increasing number of patient expiration, and low diagnostics rate are restraining factors of the market during the forecast period.
Avail Sample Market Brochure of the report for more information, Get a Copy @ https://www.researchcosmos.com/request/global-hypertension-drug-market-forecast-2017-2025-ind/8941611
Geographic Segmentation:
Based on geography, the Global Hypertension Drug market has been primarily divided into Asia Pacific, Middle East and Africa, North America and Latin America. North America holds the largest market share in the global hypertension market followed by Europe due to the increasing demand for accurate diagnosis and treatment of hypertension, early identification of people predisposed to the disease, and presence of well-established healthcare infrastructure. The Asia-Pacific is rapidly growing in medical industry due to improving healthcare facilities, favorable government reimbursement policies, increasing healthcare expenditures, rising prevalence of hypertension diseases, and increasing geriatric population.
Key Players:
Leading companies for Global Hypertension Drug market are Lupin Limited, Novartis AG, Sun Pharmaceuticals LLC, Daiichi - Sankyo, Pfizer Inc., Sanofi S.A, AstraZeneca Plc., Johnson & Johnson Ltd., Boehringer Ingelheim, and Merck & Co, Roche, Abbott, GlaxoSmithKline plc., AstraZeneca, Bayer AG, Gilead, and Actelion.
Inquire Before Buying@ https://www.researchcosmos.com/inquire/global-hypertension-drug-market-forecast-2017-2025-ind/8941611
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
kevin@researchcosmos.com
+1 888 709 8757
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hypertension Drug Market Worth USD 32.5 Billion by 2025 | CAGR of 4.89% here
News-ID: 1205564 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Hypertension
Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hypertension Pipeline Report
• DelveInsight's Hypertension…
Hypertension Drugs Market - Breaking the Pressure: Hypertension Drugs Redefining …
Newark, New Castle, USA: The "Hypertension Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hypertension Drugs Market: https://www.growthplusreports.com/report/hypertension-drugs-market/8760
This latest report researches the industry structure, sales, revenue,…
Hypertension Management Devices Market: Rise in Prevalence of Resistant Hyperten …
Market Analysis and Insights of Hypertension Management Devices Market
Hypertension Management Devices Market to account USD 9.50 billion and growing at a CAGR of 7.27% by 2032. Although there are still numerous variations available, the major market players are currently developing and testing clinical versions of hypertension treatment devices. Due to the lack of available effective medications, these medical devices are being created with the primary goal of managing cardiovascular illnesses…
Anti-hypertension - Drug Pipeline Landscape, 2022
Hypertension also known as high blood pressure is a condition where the force of blood pushing against the arterial walls of heart is consistently higher than the normal. Hypertension can be identified as primary/essential (without a known cause such as age, genetics, sedentary lifestyle, alcohol consumption, high sodium intake etc.) and secondary (due to an underlying condition as its cause such as congenital heart defects, kidney diseases, endocrinal issues, side…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017.
High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension…
